InformationPF-00835231 PF-00835231 is a 3CL pro (M pro ) inhibitor that may targets SARS-CoV-2 protease 3CL pro as a potential new treatment for COVID-19.Targets3CLproIn vitroA time-of-drug-addition approach delineates the timing of early SARS-CoV-2 life cycle steps in A549+ACE2 cells and validates PF-00835231/'s early time of action. In a model of the human polarized airway epithelium, PF-00835231 potently inhibits SARS-CoV-2 at low micromolar concentrations. PF-00835231 exhibits the potential as an effective SARS-CoV-2 antiviral.Cell Research(from reference)Cell lines:A549 cells, human airway epithelial cultures (HAEC) Concentrations:1 nM-10 μM Incubation Time:0-4 h.
Specifications and Purity: ≥98%
Molecular Formula: C24H32N4O6
Molecular Weight: 472.53
PubChem CID: 11561899
Isomeric SMILES: CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CO)NC(=O)C2=CC3=C(N2)C=CC=C3OC
Related Documents: https://aladdin-for-icloud-store.oss-cn-hangzhou.aliyuncs.com/aladdinsci/pdp/sds/1/P414478-SCI_4a13b93fae185df41078848809e99d9c.pdf
- UPC:
- 41105331
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- P414478-25mg
- CAS:
- 870153-29-0
- Product Size:
- 25mg
akash.verma@cenmed.com
(732) 447-1115





